Biochem/physiol Actions
Less active enantiomer of propranolol.
Features and Benefits
This compound was developed by AstraZeneca. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
- UPC:
- 12352323
- Condition:
- New
- HazmatClass:
- No
- MPN:
- P0689-100MG
- CAS:
- 13071-11-9
akash.verma@cenmed.com
(732) 447-1115





